Claudia R Felipe
Overview
Explore the profile of Claudia R Felipe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miranda T, Felipe C, Santos R, Medina Pestana J, Tedesco-Silva Junior H
Ther Drug Monit
. 2020 Jul;
42(6):811-820.
PMID: 32657909
Background: The safety of immunosuppressive regimens is influenced by the induction agent, maintenance drug combination, and prophylactic strategy for cytomegalovirus (CMV) infection. Herein, this safety analysis compares rabbit antithymocyte globulin...
2.
de Paula M, Bae S, Shaffer A, Garonzik-Wang J, Felipe C, Cristelli M, et al.
Transplantation
. 2020 Jan;
104(10):2139-2147.
PMID: 31978003
Background: Optimizing antithymocyte globulin (ATG) dosage is critical, particularly for high-risk kidney transplant (KT) recipients without cytomegalovirus (CMV) prophylaxis. Methods: We studied 630 KT recipients with expanded criteria donors or...
3.
Mansur J, Sandes-Freitas T, Kirsztajn G, Cristelli M, Mata G, de Paula M, et al.
Nephrology (Carlton)
. 2019 Mar;
24(11):1179-1188.
PMID: 30891898
Aim: Focal segmental glomerulosclerosis recurs in up to 30% and up to 80% of adult and pediatric kidney transplant recipients, respectively. There is no standard of care treatment. The purpose...
4.
Hiramoto L, Tedesco-Silva H, Medina-Pestana J, Felipe C
Int J Clin Pharm
. 2018 Oct;
40(6):1548-1558.
PMID: 30302621
Background Kidney transplant recipients (KTR) receive fixed daily doses of mycophenolate sodium as part of the immunosuppressive regimen. Dose reductions occur primarily due to adverse events and may be associated...
5.
Ruppel P, Felipe C, Medina-Pestana J, Hiramoto L, Viana L, Ferreira A, et al.
J Bras Nefrol
. 2018 Jun;
40(2):151-161.
PMID: 29927458
Introduction: The risk of death after kidney transplant is associated with the age of the recipient, presence of comorbidities, socioeconomic status, local environmental characteristics and access to health care. Objective:...
6.
Mine K, Tedesco-Silva H, Mourao T, Campos E, Salzedas L, Aguiar B, et al.
Hum Immunol
. 2018 May;
79(8):594-601.
PMID: 29800590
Background: Accurate pre-transplant prediction of late graft function remains an unmet need in kidney transplantation. The aim of this study was to evaluate HLA genes expression levels in pre-implantation biopsies...
7.
de Oliveira N, Paula M, Felipe C, Tedesco-Silva H, Medina-Pestana J
Clin Transplant
. 2017 Jul;
31(9).
PMID: 28665496
Objective: The risks and benefits of the participation of kidney transplant recipients in randomized clinical trials (RCTs) investigating new immunosuppressive therapies are unknown. Design And Setting: We included patients from...
8.
Tamashiro E, Felipe C, Genvigir F, Rodrigues A, Campos A, Hirata R, et al.
Drug Metab Pers Ther
. 2017 Jun;
32(2):89-95.
PMID: 28593920
Background: Polymorphisms in genes encoding for drug-metabolizing enzymes and drug transporters are among multiple factors that modulate the pharmacokinetic variability of tacrolimus (TAC) and sirolimus (SRL). This study aimed to...
9.
Salgado P, Genvigir F, Felipe C, Tedesco-Silva Jr H, Medina-Pestana J, Doi S, et al.
Pharmgenomics Pers Med
. 2017 Apr;
10:101-106.
PMID: 28435308
Background: The effects of genetic variants related to the pharmacodynamic mechanisms of immunosuppressive drugs on their therapeutic efficacy and safety have been poorly explored. This study was performed to investigate...
10.
Genvigir F, Nishikawa A, Felipe C, Tedesco-Silva Jr H, Oliveira N, Salazar A, et al.
Pharmacotherapy
. 2017 Mar;
37(5):535-545.
PMID: 28316087
Study Objective: To investigate the influence of single nucleotide polymorphisms (SNPs) in genes encoding metabolizing enzymes (CYP2C8, CYP2J2, and UGT2B7) and transporters (ABCC2 and ABCG2) on dose and dose-adjusted trough...